Euroopan unioni - suomi - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosuppressantit - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Euroopan unioni - suomi - EMA (European Medicines Agency)

leti pharma, s.l.u. - recombinant protein q from leishmania infantum mon-1 - inaktivoidut bakteerirokotteet (kuten mykoplasma -, kurkkumätä-ja klamydia) - koirat - 6 kuukauden ikäisten koirien aktiivinen immunisointi leishmaniaasin kliinisen tapauksen riskin vähentämiseksi.

Euroopan unioni - suomi - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing ltd - imidaklopridi, moksidektiini - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). eläinlääkevalmistetta voidaan käyttää osana kirppu allergiadermatiitin (fad) hoitostrategiaa,.  for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis).  for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). eläinlääkevalmistetta voidaan käyttää osana kirppu allergiadermatiitin (fad) hoitostrategiaa,.

Euroopan unioni - suomi - EMA (European Medicines Agency)

takeda pharma a/s - ixasomibisitraatti - multiple myeloma - antineoplastiset aineet - ninlaro yhdessä lenalidomidin ja deksametasonin kanssa on tarkoitettu hoidettaessa aikuispotilailla, joilla on multippeli myelooma, jotka ovat saaneet vähintään yhtä aikaisempaa hoitoa.

Suomi - suomi - Fimea (Suomen lääkevirasto)

aspen pharma trading limited - azathioprine - tabletti, kalvopäällysteinen - 50 mg - atsatiopriini

Suomi - suomi - Fimea (Suomen lääkevirasto)

aspen pharma trading limited - azathioprine - tabletti, kalvopäällysteinen - 25 mg - atsatiopriini

Suomi - suomi - Fimea (Suomen lääkevirasto)

takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 30 mg - lisdeksamfetamiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 50 mg - lisdeksamfetamiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 70 mg - lisdeksamfetamiini

Euroopan unioni - suomi - EMA (European Medicines Agency)

leo pharma a/s - tralokinumab - dermatitis, atopic - muut dermatologiset valmisteet - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.